Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life.
from Dementia Big http://ift.tt/1QZalmT via alcoholic dementia
http://ift.tt/1M2z4FE
No comments:
Post a Comment